{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:51:05Z","timestamp":1793317865368,"version":"4.5.0"},"reference-count":49,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This work examines the cellular pathophysiology associated with the weakened bone matrix found in a murine model of osteogenesis imperfecta murine (oim). Histomorphometric analysis of oim\/oim bone showed significantly diminished bone mass, and the osteoblast and osteoclast histomorphometric parameters were increased in the oim\/oim mice, compared with wild-type (+\/+) mice. To assess osteoblast activity, a rat Col1a1 promoter linked to the chloramphenicol acetyltransferase reporter transgene was bred into the oim model. At 8 d and 1 month of age, no difference in transgene activity between oim and control mice was observed. However, at 3 months of age, chloramphenicol acetyl transferase activity was elevated in oim\/oim;Tg\/Tg, compared with +\/+;Tg\/Tg and oim\/+;Tg\/Tg. High levels of urinary pyridinoline crosslinks in the oim\/oim;Tg\/Tg mice were present at all ages, reflecting continuing high bone resorption. Our data portray a state of ineffective osteogenesis in which the mutant mouse never accumulates a normal quantity of bone matrix. However, it is only after the completion of the rapid growth phase that the high activity of the oim\/oim osteoblast can compensate for the high rate of bone resorption. This relationship between bone formation and resorption may explain why the severity of osteogenesis imperfecta decreases after puberty is completed. The ability to quantify high bone turnover and advantages of using a transgene that reflects osteoblast lineage activity make this a useful model for studying interventions designed to improve the bone strength in osteogenesis imperfecta.<\/jats:p>","DOI":"10.1210\/endo.143.5.8807","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T16:12:05Z","timestamp":1389197525000},"page":"1594-1601","source":"Crossref","is-referenced-by-count":46,"title":["Osteoblastic Response to the Defective Matrix in the Osteogenesis Imperfecta Murine (oim) Mouse"],"prefix":"10.1210","volume":"143","author":[{"given":"I.","family":"Kalajzic","sequence":"first","affiliation":[{"name":"Department of Genetics and Developmental Biology (I.K., Z.R., K.M., S.H.C., D.W.R.), University of Connecticut Health Center, Farmington, Connecticut 06030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Terzic","sequence":"additional","affiliation":[{"name":"Department of Physiology (J.T.), University School of Medicine, Split 21000, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Rumboldt","sequence":"additional","affiliation":[{"name":"Department of Genetics and Developmental Biology (I.K., Z.R., K.M., S.H.C., D.W.R.), University of Connecticut Health Center, Farmington, Connecticut 06030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Mack","sequence":"additional","affiliation":[{"name":"Department of Genetics and Developmental Biology (I.K., Z.R., K.M., S.H.C., D.W.R.), University of Connecticut Health Center, Farmington, Connecticut 06030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Naprta","sequence":"additional","affiliation":[{"name":"Orthopedics (A.N., F.L., G.G.), University of Connecticut Health Center, Farmington, Connecticut 06030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ledgard","sequence":"additional","affiliation":[{"name":"Orthopedics (A.N., F.L., G.G.), University of Connecticut Health Center, Farmington, Connecticut 06030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Gronowicz","sequence":"additional","affiliation":[{"name":"Orthopedics (A.N., F.L., G.G.), University of Connecticut Health Center, Farmington, Connecticut 06030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. H.","family":"Clark","sequence":"additional","affiliation":[{"name":"Department of Genetics and Developmental Biology (I.K., Z.R., K.M., S.H.C., D.W.R.), University of Connecticut Health Center, Farmington, Connecticut 06030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. W.","family":"Rowe","sequence":"additional","affiliation":[{"name":"Department of Genetics and Developmental Biology (I.K., Z.R., K.M., S.H.C., D.W.R.), University of Connecticut Health Center, Farmington, Connecticut 06030"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071620140894400_R1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jmg.16.2.101","article-title":"Genetic heterogeneity in osteogenesis imperfecta.","volume":"16","author":"Sillence","year":"1979","journal-title":"J Med Genet"},{"key":"2020071620140894400_R2","first-page":"889","author":"Shapiro","year":"1996"},{"key":"2020071620140894400_R3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev.me.43.020192.001413","article-title":"Osteogenesis imperfecta","volume":"43","author":"Byers","year":"1992","journal-title":"Annu Rev Med"},{"key":"2020071620140894400_R4","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1096\/fasebj.5.7.2010058","article-title":"Mutations in collagen genes: causes of rare and some common diseases in humans.","volume":"5","author":"Kuivaniemi","year":"1991","journal-title":"FASEB J"},{"key":"2020071620140894400_R5","first-page":"1353","article-title":"Physiology and pathophysiology of bone remodeling [published erratum appears in Clin Chem 1999;45:1885].","volume":"45","author":"Raisz","year":"1999","journal-title":"Clin Chem"},{"key":"2020071620140894400_R6","doi-asserted-by":"crossref","unstructured":"Fazzalari NL 1993 Trabecular microfracture. Calcif Tissue Int 53:S143-S146; discussion S146-S147","DOI":"10.1007\/BF01673424"},{"key":"2020071620140894400_R7","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1203\/00006450-198303000-00007","article-title":"Increased bone turnover with decreased bone formation by osteoblasts in children with osteogenesis imperfecta tarda.","volume":"17","author":"Baron","year":"1983","journal-title":"Pediatr Res"},{"key":"2020071620140894400_R8","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S8756-3282(00)00269-6","article-title":"Static and dynamic bone histomorphometry in children with osteogenesis imperfecta.","volume":"26","author":"Rauch","year":"2000","journal-title":"Bone"},{"key":"2020071620140894400_R9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/6529","article-title":"Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta.","volume":"5","author":"Horwitz","year":"1999","journal-title":"Nat Med"},{"key":"2020071620140894400_R10","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","article-title":"Cyclic administration of pamidronate in children with severe osteogenesis imperfecta.","volume":"339","author":"Glorieux","year":"1998","journal-title":"N Engl J Med"},{"key":"2020071620140894400_R11","first-page":"1846","article-title":"Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age.","volume":"85","author":"Plotkin","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071620140894400_R12","doi-asserted-by":"crossref","first-page":"23373","DOI":"10.1016\/S0021-9258(18)54506-3","article-title":"Transgenic mice that express a mini-gene version of the human gene for type I procollagen (COL1A1) develop a phenotype resembling a lethal form of osteogenesis imperfecta.","volume":"266","author":"Khillan","year":"1991","journal-title":"J Biol Chem"},{"key":"2020071620140894400_R13","doi-asserted-by":"crossref","first-page":"37923","DOI":"10.1074\/jbc.274.53.37923","article-title":"Use of the Cre\/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an \u03b11(I) G349C substitution. Variability in phenotype in BrtlIV mice.","volume":"274","author":"Forlino","year":"1999","journal-title":"J Biol Chem"},{"key":"2020071620140894400_R14","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1073\/pnas.90.5.1701","article-title":"Defective pro \u03b1 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta.","volume":"90","author":"Chipman","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071620140894400_R15","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(79)91872-5","article-title":"Biochemical heterogeneity of osteogenesis imperfecta: new variant.","volume":"1","author":"Nicholls","year":"1979","journal-title":"Lancet"},{"key":"2020071620140894400_R16","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1016\/S0021-9258(18)94032-9","article-title":"Isolation and characterization of the rat \u03b1 1(I) collagen promoter. Regulation by 1,25-dihydroxyvitamin D.","volume":"264","author":"Lichtler","year":"1989","journal-title":"J Biol Chem"},{"key":"2020071620140894400_R17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1083\/jcb.116.1.227","article-title":"Differential utilization of regulatory domains within the \u03b1 1(I) collagen promoter in osseous and fibroblastic cells.","volume":"116","author":"Pavlin","year":"1992","journal-title":"J Cell Biol"},{"key":"2020071620140894400_R18","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2144\/96212bm03","article-title":"PCR genotyping of oim mutant mice.","volume":"21","author":"Saban","year":"1996","journal-title":"Biotechniques"},{"key":"2020071620140894400_R19","author":"Bancroft","year":"1990"},{"key":"2020071620140894400_R20","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"key":"2020071620140894400_R21","first-page":"264","article-title":"An improved fluor diffusion assay for chloramphenicol acetyltransferase gene expression.","volume":"16","author":"Purschke","year":"1994","journal-title":"Biotechniques"},{"key":"2020071620140894400_R22","doi-asserted-by":"crossref","first-page":"6210","DOI":"10.1021\/bi00320a049","article-title":"Construction of DNA sequences complementary to rat \u03b1 1 and \u03b1 2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D.","volume":"23","author":"Genovese","year":"1984","journal-title":"Biochemistry"},{"key":"2020071620140894400_R23","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/j.1460-2075.1986.tb04440.x","article-title":"Isolation of the human gene for bone gla protein utilizing mouse and rat cDNA clones.","volume":"5","author":"Celeste","year":"1986","journal-title":"EMBO J"},{"key":"2020071620140894400_R24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/BF00292337","article-title":"Murine bone sialoprotein (BSP): cDNA cloning, mRNA expression, and genetic mapping.","volume":"5","author":"Young","year":"1994","journal-title":"Mamm Genome"},{"key":"2020071620140894400_R25","author":"Sambrook","year":"1989"},{"key":"2020071620140894400_R26","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1359\/jbmr.2001.16.7.1228","article-title":"Col1a1-driven transgenic markers of osteoblast lineage progression.","volume":"16","author":"Dacic","year":"2001","journal-title":"J Bone Miner Res"},{"key":"2020071620140894400_R27","first-page":"E724","article-title":"Tissue-specific expression of bone proteins in femora of growing rats","volume":"263","author":"Turner","year":"1992","journal-title":"Am J Physiol"},{"key":"2020071620140894400_R28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1210\/endo-125-1-327","article-title":"1,25-Dihydroxyvitamin D3 inhibits transcription of type I collagen genes in the rat osteosarcoma cell line ROS 17\/2.8.","volume":"125","author":"Harrison","year":"1989","journal-title":"Endocrinology"},{"key":"2020071620140894400_R29","first-page":"399","article-title":"Parathyroid hormone represses \u03b11(I) collagen promoter activity in cultured calvariae from neonatal transgenic mice.","volume":"7","author":"Kream","year":"1993","journal-title":"Mol Endocrinol"},{"key":"2020071620140894400_R30","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1359\/jbmr.1998.13.7.1076","article-title":"Interleukin-1 represses COLIA1 promoter activity in calvarial bones of transgenic ColCAT mice in vitro and in vivo.","volume":"13","author":"Harrison","year":"1998","journal-title":"J Bone Miner Res"},{"key":"2020071620140894400_R31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0167-4781(98)00079-7","article-title":"1,25-Dihydroxyvitamin D3 inhibition of col1a1 promoter expression in calvariae from neonatal transgenic mice.","volume":"1398","author":"Bedalov","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"2020071620140894400_R32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/(SICI)1097-4644(20000401)77:1<149::AID-JCB15>3.0.CO;2-N","article-title":"Parathyroid hormone inhibits collagen synthesis and the activity of rat col1a1 transgenes mainly by a cAMP-mediated pathway in mouse calvariae.","volume":"77","author":"Bogdanovic","year":"2000","journal-title":"J Cell Biochem"},{"key":"2020071620140894400_R33","first-page":"E348","article-title":"Correlation between mRNA levels for bone cell proteins and bone formation in long bones of maturing rats","volume":"261","author":"Turner","year":"1991","journal-title":"Am J Physiol"},{"key":"2020071620140894400_R34","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/jbmr.5650090706","article-title":"Bone resorption assessed by immunoassay of urinary cross-linked collagen peptides in patients with osteogenesis imperfecta.","volume":"9","author":"Brenner","year":"1994","journal-title":"J Bone Miner Res"},{"key":"2020071620140894400_R35","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1056\/NEJM198406283102602","article-title":"Osteogenesis imperfecta after the menopause.","volume":"310","author":"Paterson","year":"1984","journal-title":"N Engl J Med"},{"key":"2020071620140894400_R36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0945-053X(94)90189-9","article-title":"Deposition and selective degradation of structurally-abnormal type I collagen in a collagen matrix produced by osteogenesis imperfecta fibroblasts in vitro.","volume":"14","author":"Bateman","year":"1994","journal-title":"Matrix Biol"},{"key":"2020071620140894400_R37","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1651-2227.1998.tb00920.x","article-title":"Collagen-derived markers of bone metabolism in osteogenesis imperfecta.","volume":"87","author":"Lund","year":"1998","journal-title":"Acta Paediatr"},{"key":"2020071620140894400_R38","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1651-2227.1998.tb01388.x","article-title":"Beneficial effect of bisphosphonate during five years of treatment of severe osteogenesis imperfecta.","volume":"87","author":"Astrom","year":"1998","journal-title":"Acta Paediatr"},{"key":"2020071620140894400_R39","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/jbmr.5650101113","article-title":"Cell proliferation of human fibroblasts and osteoblasts in osteogenesis imperfecta: influence of age.","volume":"10","author":"Fedarko","year":"1995","journal-title":"J Bone Miner Res"},{"key":"2020071620140894400_R40","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1006\/scdb.1999.0317","article-title":"Procollagen folding and assembly: the role of endoplasmic reticulum enzymes and molecular chaperones.","volume":"10","author":"Lamande","year":"1999","journal-title":"Semin Cell Dev Biol"},{"key":"2020071620140894400_R41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S8756-3282(97)00075-6","article-title":"Effect of rhBMP-2 on the osteogenic potential of bone marrow stromal cells from an osteogenesis imperfecta mouse (oim).","volume":"21","author":"Balk","year":"1997","journal-title":"Bone"},{"key":"2020071620140894400_R42","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/jbmr.5650110611","article-title":"Long-term extracellular matrix metabolism by cultured human osteogenesis imperfecta osteoblasts.","volume":"11","author":"Fedarko","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2020071620140894400_R43","doi-asserted-by":"crossref","first-page":"8642","DOI":"10.1074\/jbc.270.15.8642","article-title":"Endoplasmic reticulum-mediated quality control of type I collagen production by cells from osteogenesis imperfecta patients with mutations in the pro \u03b11 (I) chain carboxyl-terminal propeptide which impair subunit assembly.","volume":"270","author":"Lamande","year":"1995","journal-title":"J Biol Chem"},{"key":"2020071620140894400_R44","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/(SICI)1096-9896(199802)184:2<212::AID-PATH996>3.0.CO;2-Z","article-title":"The retention of abnormal type I procollagen and correlated expression of HSP 47 in fibroblasts from a patient with lethal osteogenesis imperfecta.","volume":"184","author":"Kojima","year":"1998","journal-title":"J Pathol"},{"key":"2020071620140894400_R45","doi-asserted-by":"crossref","first-page":"27392","DOI":"10.1074\/jbc.274.39.27392","article-title":"Proteasomal degradation of unassembled mutant type I collagen pro-\u03b11(I) chains.","volume":"274","author":"Fitzgerald","year":"1999","journal-title":"J Biol Chem"},{"key":"2020071620140894400_R46","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1083\/jcb.150.6.1499","article-title":"Embryonic lethality of molecular chaperone hsp47 knockout mice is associated with defects in collagen biosynthesis.","volume":"150","author":"Nagai","year":"2000","journal-title":"J Cell Biol"},{"key":"2020071620140894400_R47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1359\/jbmr.2002.17.1.15","article-title":"Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage.","volume":"17","author":"Kalajzic","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2020071620140894400_R48","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ajmg.1320450223","article-title":"Evaluation of growth hormone axis and responsiveness to growth stimulation of short children with osteogenesis imperfecta.","volume":"45","author":"Marini","year":"1993","journal-title":"Am J Med Genet"},{"key":"2020071620140894400_R49","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S8756-3282(99)00186-6","article-title":"Effect of growth hormone treatment on calcium kinetics in patients with osteogenesis imperfecta type III and IV.","volume":"25","author":"Vieira","year":"1999","journal-title":"Bone"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/143\/5\/1594\/10366920\/endo1594.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/143\/5\/1594\/10366920\/endo1594.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T23:23:24Z","timestamp":1647905004000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/143\/5\/1594\/2989234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5,1]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/endo.143.5.8807","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,5,1]]}}}